Using cell culture and in vivo models of melanoma, we provide evidence indicating that the expression of CAV1 strongly represses the ability of cancer cells to engage the UPR, ablating an adaptive capacity to cope with ER stress. This evidence concerns the gene CAV1 and melanoma.